David Slosky

older man

Prostate cancer survivors’ risk of heart disease studied

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

Cancer therapies’ impact on heart, kidneys explored

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.

Program focuses on heart health of cancer patients

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.

VHVI at Williamson Medical Center set to open

Vanderbilt Heart at Williamson Medical Center opens Jan. 6